AKT1 and cancer: These results suggest that PDK-1, which is an upstream regulator of AKT, may be an attractive therapeutic target for cancer intervention in RMS and OSU-03012 might be a potential therapeutic treatment for RMS patients, especially those cases with PDK-1/AKT pathway activated.